譽衡藥業(002437.SZ):控股股東所持8600萬股司法拍賣過户完成
格隆匯12月9日丨譽衡藥業(002437.SZ)公佈,2019年12月9日,公司收到湖北省武漢市江岸區人民法院出具的《執行裁定書》((2018)鄂0102執2629、2630、2635-2638號、(2019)鄂0102執2512-2516、8811、8812號),裁定如下:
1、解除對譽衡集團持有的公司8600萬股無限售流通股的凍結措施。
2、解除譽衡集團持有的公司8600萬股無限售流通股對武漢信用小額貸股份有限公司的質押。
3、譽衡集團持有的公司8600萬股無限售流通股歸買受人天風證券股份有限公司所有,上述無限售流通股自本裁定送達給買受人天風證券股份有限公司時起轉移。
4、買受人天風證券股份有限公司可持本裁定到登記機構辦理相關產權變更登記手續。
2019年12月9日,公司通過中國證券登記結算有限責任公司深圳分公司系統查詢,獲悉譽衡集團被司法拍賣的8600萬股公司股票已完成股份變更過户手續,譽衡集團持有的公司股份數量已下降至約8.3億股,佔公司總股本的37.77%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.